FierceBiotech ١٠ ديسمبر ٢٠٢٥ Chinese biotech led by AstraZeneca veteran reels in $108M for KRAS phase 3 plans Chinese biotech led by AstraZeneca veteran reels in $108M for KRAS phase 3 plans المصدر